DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,129 filers reported holding DANAHER CORPORATION in Q2 2017. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $998,901 | -0.6% | 3,998 | -0.6% | 0.20% | +1.0% |
Q1 2024 | $1,004,624 | +19.5% | 4,023 | +10.7% | 0.20% | +11.0% |
Q4 2023 | $840,920 | -6.9% | 3,635 | -0.1% | 0.18% | -14.6% |
Q3 2023 | $903,084 | +7.8% | 3,640 | +4.3% | 0.21% | +11.6% |
Q2 2023 | $837,600 | -3.3% | 3,490 | +1.6% | 0.19% | -7.8% |
Q1 2023 | $865,758 | +94933.8% | 3,435 | +0.1% | 0.21% | -6.8% |
Q4 2022 | $911 | -99.9% | 3,433 | +1.6% | 0.22% | -2.6% |
Q3 2022 | $873,000 | +1.7% | 3,378 | -0.2% | 0.23% | +11.3% |
Q2 2022 | $858,000 | -59.0% | 3,386 | -52.6% | 0.20% | -48.0% |
Q1 2022 | $2,094,000 | -10.9% | 7,138 | 0.0% | 0.39% | -6.0% |
Q4 2021 | $2,349,000 | +10.3% | 7,138 | +2.0% | 0.42% | +0.7% |
Q3 2021 | $2,129,000 | +13.8% | 6,995 | +0.4% | 0.41% | +15.3% |
Q2 2021 | $1,871,000 | +21.7% | 6,970 | +2.0% | 0.36% | +12.5% |
Q1 2021 | $1,538,000 | -20.6% | 6,830 | -21.7% | 0.32% | -24.9% |
Q4 2020 | $1,938,000 | +21.0% | 8,724 | +17.3% | 0.42% | +4.2% |
Q3 2020 | $1,601,000 | +11.7% | 7,436 | -8.3% | 0.41% | +3.8% |
Q2 2020 | $1,433,000 | +43.3% | 8,107 | +12.2% | 0.39% | +19.8% |
Q1 2020 | $1,000,000 | -4.1% | 7,225 | +6.3% | 0.33% | +17.1% |
Q4 2019 | $1,043,000 | +8.9% | 6,795 | +2.4% | 0.28% | -1.8% |
Q3 2019 | $958,000 | +13.1% | 6,637 | +12.1% | 0.28% | +11.3% |
Q2 2019 | $847,000 | +4.2% | 5,922 | -3.9% | 0.26% | +3.2% |
Q1 2019 | $813,000 | +19.7% | 6,160 | -6.5% | 0.25% | +5.5% |
Q4 2018 | $679,000 | -8.0% | 6,586 | -3.0% | 0.24% | +6.8% |
Q3 2018 | $738,000 | +31.6% | 6,787 | +19.4% | 0.22% | +22.2% |
Q2 2018 | $561,000 | -0.9% | 5,685 | -1.6% | 0.18% | -2.7% |
Q1 2018 | $566,000 | -1.0% | 5,780 | -6.2% | 0.18% | +20.9% |
Q4 2017 | $572,000 | +10.6% | 6,162 | +2.2% | 0.15% | -14.5% |
Q3 2017 | $517,000 | +14.4% | 6,028 | +12.5% | 0.18% | +9.8% |
Q2 2017 | $452,000 | +26.3% | 5,356 | +27.9% | 0.16% | +24.4% |
Q1 2017 | $358,000 | -12.7% | 4,188 | -20.4% | 0.13% | -8.4% |
Q4 2016 | $410,000 | -29.9% | 5,259 | -29.4% | 0.14% | -40.4% |
Q3 2016 | $585,000 | -3.0% | 7,454 | +24.8% | 0.24% | -5.9% |
Q2 2016 | $603,000 | +4.5% | 5,974 | -1.8% | 0.26% | -1.5% |
Q1 2016 | $577,000 | -3.4% | 6,082 | -5.4% | 0.26% | -8.2% |
Q4 2015 | $597,000 | +35.4% | 6,429 | +24.1% | 0.28% | +16.0% |
Q3 2015 | $441,000 | +13.4% | 5,182 | +13.1% | 0.24% | +25.9% |
Q2 2015 | $389,000 | 0.0% | 4,580 | 0.0% | 0.19% | 0.0% |
Q1 2015 | $389,000 | +4.0% | 4,580 | +4.9% | 0.19% | -2.0% |
Q4 2014 | $374,000 | +37.5% | 4,364 | +21.8% | 0.20% | +19.4% |
Q3 2014 | $272,000 | -8.4% | 3,583 | -4.8% | 0.16% | -7.8% |
Q2 2014 | $297,000 | +14.7% | 3,765 | +9.0% | 0.18% | +9.8% |
Q1 2014 | $259,000 | +17.7% | 3,455 | +21.6% | 0.16% | +19.0% |
Q4 2013 | $220,000 | – | 2,842 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |